Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 1;320(1):H404-H410.
doi: 10.1152/ajpheart.00897.2020. Epub 2020 Dec 11.

Vascular alterations among young adults with SARS-CoV-2

Affiliations

Vascular alterations among young adults with SARS-CoV-2

Stephen M Ratchford et al. Am J Physiol Heart Circ Physiol. .

Abstract

While SARS-CoV-2 primarily affects the lungs, the virus may be inflicting detriments to the cardiovascular system, both directly through angiotensin-converting enzyme 2 receptor and initiating systemic inflammation. Persistent systemic inflammation may be provoking vascular dysfunction, an early indication of cardiovascular disease risk. To establish the potential effects of SARS-CoV-2 on the systemic vasculature in the arms and legs, we performed a cross-sectional analysis of young healthy adults (control: 5 M/15 F, 23.0 ± 1.3 y, 167 ± 9 cm, 63.0 ± 7.4 kg) and young adults who, 3-4 wk prior to testing, had tested positive for SARS-CoV-2 (SARS-CoV-2: 4 M/7 F, 20.2 ± 1.1 y, 172 ± 12 cm, 69.5 ± 12.4 kg) (means ± SD). Using Doppler ultrasound, brachial artery flow-mediated dilation (FMD) in the arm and single passive limb movement (sPLM) in the leg were assessed as markers of vascular function. Carotid-femoral pulse wave velocity (PWVcf) was asvsessed as a marker of arterial stiffness. FMD was lower in the SARS-CoV-2 group (2.71 ± 1.21%) compared with the control group (8.81 ± 2.96%) (P < 0.01) and when made relative to the shear stimulus (SARS-CoV-2: 0.04 ± 0.02 AU, control: 0.13 ± 0.06 AU, P < 0.01). The femoral artery blood flow response, as evidenced by the area under the curve, from the sPLM was lower in the SARS-CoV-2 group (-3 ± 91 mL) compared with the control group (118 ± 114 mL) (P < 0.01). PWVcf was higher in the SARS-CoV-2 group (5.83 ± 0.62 m/s) compared with the control group (5.17 ± 0.66 m/s) (P < 0.01). Significantly lower systemic vascular function and higher arterial stiffness are evident weeks after testing positive for SARS-CoV-2 among young adults compared with controls.NEW & NOTEWORTHY This study was the first to investigate the vascular implications of contracting SARS-CoV-2 among young, otherwise healthy adults. Using a cross-sectional design, this study assessed vascular function 3-4 wk after young adults tested positive for SARS-CoV-2. The main findings from this study were a strikingly lower vascular function and a higher arterial stiffness compared with healthy controls. Together, these results suggest rampant vascular effects seen weeks after contracting SARS-CoV-2 in young adults.

Keywords: COVID-19; SARS-CoV-2; flow-mediated dilation; passive limb movement; pulse wave velocity.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Brachial artery flow-mediated dilation (FMD) expressed as percentage change (A) and normalized to shear (B). Two-tailed Student’s t tests for two samples of equal variance were performed between control (n = 5 M/15 F) and SARS-CoV-2 (n = 4 M/7 F) groups. *P < 0.01, between groups. Data are means ± SD.
Figure 2.
Figure 2.
Single passive limb movement. Common femoral artery blood flow change from baseline following a single passive limb movement (A) with the 60-s area under the curve (B). Two-tailed Student’s t tests for two samples of equal variance were performed between control (n = 5 M/15 F) and SARS-CoV-2 (n = 4 M/7 F) groups. *P < 0.01, between groups. Data are means ± SD.
Figure 3.
Figure 3.
Carotid-femoral pulse wave velocity. Two-tailed Student’s t tests for two samples of equal variance were performed between control (n = 5 M/15 F) and SARS-CoV-2 (n = 4 M/7 F) groups. *P < 0.01, between groups. Data are means ± SD.

Comment in

References

    1. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395: 1054–1062, 2020. doi:10.1016/S0140-6736(20)30566-3. - DOI - PMC - PubMed
    1. Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, Diz DI, Gallagher PE. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 111: 2605–2610, 2005. doi:10.1161/CIRCULATIONAHA.104.510461. - DOI - PubMed
    1. Monteil V, Kwon H, Prado P, Hagelkruys A, Wimmer RA, Stahl M, Leopoldi A, Garreta E, Hurtado Del Pozo C, Prosper F, Romero JP, Wirnsberger G, Zhang H, Slutsky AS, Conder R, Montserrat N, Mirazimi A, Penninger JM. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell 181: 905–913.e7, 2020. doi:10.1016/j.cell.2020.04.004. - DOI - PMC - PubMed
    1. Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol 39: 529–539, 2017. doi:10.1007/s00281-017-0629-x. - DOI - PMC - PubMed
    1. Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M. The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev 53: 25–32, 2020. doi:10.1016/j.cytogfr.2020.05.003. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources